As of May 26
| -0.02 / -0.50%|
The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +99.00% increase from the last price of 4.02.
The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.